MetaCap

Ispire Technology (ISPR) vs Mannatech (MTEX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Ispire Technology (ISPR) has outperformed Mannatech (MTEX) over the past year, losing 43.6% versus a loss of 73.8%. Ispire Technology is the larger company by market cap ($71.1 million vs $4.9 million), about 14.4 times the size, while Mannatech is growing revenue faster (-8.3% vs -24.7%). Mannatech converts more of its revenue into profit, with a net margin of -14.1% versus -34.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ISPR-43.58%MTEX-73.80%
+76%-3%-82%
Nov 21, 20251 yearNov 20, 2026
ISPR-82.63%MTEX-84.49%
+85%-4%-93%
Apr 3, 20235 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ISPR versus MTEX key metrics
MetricISPRMTEX
Share price$1.23$2.56
Market cap$71.05M$4.94M
1-day change-3.15%+5.13%
YTD return-56.07%-68.97%
1-year return-43.58%-73.80%
5-year return—-93.33%
EPS (TTM)$-0.64$-0.31
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$96.01M$108.04M
Revenue growth (YoY)-24.69%-8.34%
Net income (latest FY)$-33.20M$-15.21M
Gross margin12.81%74.94%
Operating margin-33.95%-0.39%
Net margin-34.58%-14.08%
52-week high$3.87$9.97
52-week low$1.01$2.32
Distance from 52-week high-68.22%-74.32%
Analyst consensusstrong_buy—
Avg. price target upside+298.37%—
Average volume20.51K37.23K
Shares outstanding57.77M1.93M
Employees88170
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Ispire Technology is about 14.4 times larger than Mannatech by market value ($71.05M vs $4.94M).
  • ISPR has outperformed MTEX by 30.2 percentage points over the past year.
  • Mannatech is more profitable, keeping -14.1 cents of every revenue dollar as net income versus -34.6 cents for Ispire Technology.
  • Mannatech grew revenue faster in its latest fiscal year (-8.34% vs -24.69%).

About Ispire Technology

ISPR stock →

Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Aspire brands.

Health Care · Medicinal Chemicals and Botanical Products · 88 employees

About Mannatech

MTEX stock →

Mannatech, Incorporated operates as a wellness solution provider. The company develops markets and sells nutritional supplements; skin care and anti-aging products; and weight-management and fitness products.

Health Care · Medicinal Chemicals and Botanical Products · 170 employees

ISPR vs MTEX FAQ

Which is bigger, Ispire Technology or Mannatech?

Ispire Technology (ISPR) is larger, with a market capitalization of $71.05M compared with $4.94M for Mannatech (MTEX).

Which stock has performed better over the past year, ISPR or MTEX?

ISPR returned -43.58% over the past 12 months, compared with -73.80% for MTEX (price return, excluding dividends). Past performance does not predict future results.

Are Ispire Technology and Mannatech in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons